What NanoSphere Health Sciences does

NanoSphere Health Sciences Inc is a Canada-domiciled, publicly listed biotechnology company (CNQ/CSE: NSHS; formerly Corazon Gold Corp) that develops and commercializes the NanoSphere Delivery System (NDS), a proprietary nanoparticle platform that forms a viscoelastic matrix and encapsulates bioactive ingredients into nanosized particles to improve solubility, stability and pharmacokinetic/pharmacodynamic performance. The technology is positioned for use across cannabis, nutraceuticals, over-the-counter medicines, pharmaceuticals and animal health. The company operates through a wholly owned US biotech subsidiary, NanoSphere Health Sciences LLC, headquartered in Vancouver, BC with a listed presence in Greenwood Village, Colorado.

Commercially, NanoSphere runs a hybrid platform-plus-products model. It generates product revenue through its Evolve Formulas brand, most notably NanoSerum, a clinically tested transdermal cannabis pain-relief product distributed through Colorado's recreational and medical cannabis dispensaries. It also runs joint venture partnerships with external companies for nano-delivery research and new product development, with NDS-capable facilities positioned at or near partner locations to enable scalable co-development. The GTM motion is therefore a mix of consumer-channel distribution in a single US state and B2B JV/licensing-style platform deployment, supported by an organic social presence on Facebook, LinkedIn and Twitter.

The company is small (1–10 employees) with a thin disclosed capital history (a single ~$1M round in December 2018), no published revenue, no disclosed management team, and no AI/ML capability disclosed. The principal upside drivers are platform optionality across multiple regulated verticals and large addressable markets in liposomal/nanocapsule drug delivery; the principal risks are single-product, single-state, single-channel revenue concentration and limited operating runway evidence post-2018.

Name

NanoSphere Health Sciences

Legal name

Nanosphere Health Sciences Inc

Website

https://nanospherehealth.com

Company type

Public

Founded year

2005

Operating status

Operating

Headcount range

1–10 employees

Short description

NanoSphere Health Sciences is a publicly listed Canadian biotech that develops the NanoSphere Delivery System (NDS), a proprietary nanoparticle encapsulation platform applied to cannabis, nutraceuticals, OTC medicines, pharmaceuticals, and animal health, and sells finished products such as NanoSerum through Colorado cannabis dispensaries.

Ownership category

akta.pro rank

Product category

Nanoparticle Drug Delivery / Pharmaceutical Delivery Systems

NAICS

Research and Development in Nanotechnology (541713), Medicinal and Botanical Manufacturing (325411), Scientific Research and Development Services (5417)

SIC

Medicinal Chemicals & Botanical Products (2833)

akta.pro primary industry

Connected Therapeutics & Smart Drug Delivery Monitoring (HLACAFAL)

akta.pro secondary industry

Pain Management & Anesthesiology Pharmaceuticals (HLAIAAAN)

Keywords

• Nanoparticle drug delivery
• Transdermal cannabis products
• Biotechnology delivery platform
• Nutraceutical nanoencapsulation
• Bioactive absorption technology

Headquarters

HQ city

Greenwood Village

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B and B2C

Offering type

Hardware or Manufacturing

Cost components

Operations, Personnel, Technology or R&D, Marketing or Sales, Supply Chain

Revenue model

1. Product Sales - Evolve Formulas Brand: Sale of nanoparticle-based cannabis products under the Evolve Formulas brand, including NanoSerum transdermal cannabis product for pain relief, distributed through Colorado recreational and medical cannabis markets.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

NanoSphere Health Sciences develops and commercializes the NanoSphere Delivery System (NDS), a proprietary nanoparticle platform that encapsulates bioactive ingredients into nanosized particles within a viscoelastic matrix to overcome solubility, stability, and absorption limitations. The company commercializes the technology through its Evolve Formulas brand, including NanoSerum, a clinically tested transdermal cannabis product for pain relief distributed through Colorado dispensaries, and licenses the platform to joint venture partners operating in cannabis, pharmaceuticals, nutraceuticals, OTC medicines, and animal health.

Product overview

NanoSphere Health Sciences Inc is a biotechnology company that operates as a platform-plus-products business. The core technology is the NanoSphere Delivery System (NDS), a nanoparticle delivery platform that creates viscoelastic matrices and encapsulates bioactive ingredients into nanosized particles for enhanced pharmacokinetic properties. The company commercializes this technology through its Evolve Formulas brand, which offers finished products like NanoSerum—a clinically tested transdermal cannabis product for pain relief marketed in Colorado's recreational and medical cannabis markets. The NDS platform is also positioned for use in dietary supplements, nutraceuticals, OTC medicines, and animal health applications.

Differentiator

Problem solved

Functional benefit

Products and services

• NanoSphere Delivery System (NDS)
• NanoSerum
• Evolve Formulas

Named customers1 record

Segments1 record

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature1 record

Partnerships

One partnership is on record.

• Joint Venture PartnerscoreStrategic or Co-development PartnerJV partners conduct leading edge nano-delivery and new product research using the NanoSphere Delivery System. Facilities are scalable and readily set up at or near JV partner locations. The company enables partners to transform their products using NDS technology.

Scale indicators2 records

Recent moves4 records

Expansion highlights3 records

Direct peers

• Foria Wellness: Foria markets cannabis-based topicals, tinctures, and suppositories emphasizing bioavailability and delivery innovation. It overlaps with NanoSphere in using differentiated delivery formats as the brand's central differentiator in cannabis wellness.
• Lexaria Bioscience: Lexaria develops DehydraTECH, a proprietary lipid-based delivery technology for cannabinoids and other bioactive compounds. It is the closest direct peer to NanoSphere, offering an alternative IP-protected delivery platform targeting the same cannabis, nutraceutical, and pharmaceutical customers.
• Quicksilver Scientific: Quicksilver Scientific uses liposomal and nano-emulsification delivery for supplements and nutraceuticals. Like NanoSphere, it commercializes advanced delivery science through finished branded products rather than purely as a CDMO.
• Mary's Medicinals / Mary's Nutritionals: Mary's is a branded cannabis wellness company known for transdermal patches, topicals, and other delivery-focused formats. It competes with NanoSphere's Evolve Formulas / NanoSerum line in the same dispensary-channel pain relief segment.

Emerging players

• Selecta Biosciences: Selecta develops nanoparticle-based immunotherapies and tolerogenic platforms, demonstrating how nano-delivery IP can be applied in therapeutics. It is a comparable emerging platform player, though focused on biologics rather than cannabis/nutraceuticals.
• Lief Organics: Lief formulates plant-based wellness products with an emphasis on bioavailability and delivery formats. It is comparable to NanoSphere's nutraceutical ambitions as a small branded player competing on delivery-quality differentiation rather than commodity ingredients.
• Zynerba Pharmaceuticals: Zynerba focuses on transdermal cannabinoid therapeutics for rare neurological and psychiatric conditions. It is comparable to NanoSphere in applying transdermal delivery to cannabis-derived bioactives, but at a much more clinical-pharmaceutical stage.
• Elixinol: Elixinol produces hemp-derived CBD products globally with an emphasis on hemp sourcing and formulation quality. It is comparable to NanoSphere as a branded, delivery-aware cannabis/nutraceutical product company targeting similar consumer health use cases.

Broad incumbents

• Catalent: Catalent is a large global CDMO with deep capabilities in oral, injectable, and advanced drug delivery technologies. It represents the incumbent end of the nanoparticle/delivery technology spectrum against which NanoSphere's platform would compete for partner deals.

Regional players

• NutraLife Sciences: NutraLife Sciences manufactures and distributes nano-encapsulated supplements and CBD products through white-label and branded channels. It is a relevant peer to NanoSphere in nano-formulated nutraceutical/cannabis manufacturing, though with a broader contract-manufacturing angle.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat2 records

Key risks6 records

Key highlights5 records

Customer concentration

• Xx.com/GetNanoSphere
• Facebookfacebook.com/nanospherehealth
• LinkedInlinkedin.com/company/nanosphere-health-sciences-llc

Revenue estimate

Valuation estimate

Number of profiles

Subsidiaries1 record

Funding overview

Funding rounds1 record

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about NanoSphere Health Sciences